Jupiter Neurosciences, Inc.JUNS

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$2.88
Market cap
—
P/E
—
Revenue (TTM)
$21,796
Net income
-$9.2M
Dividend yield
—
1-year total return
-97.3%
Net margin
—
Revenue growth
—
Debt / equity
—

What Jupiter Neurosciences, Inc. does.

other sections of this Annual Report on Form 10-K, includes statistical and other industry and market data that we obtained from industry

publications and research, surveys and studies conducted by third parties. Industry publications and third-party research, surveys and

studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue——$0$21,796
Net income—-$4.8M-$2.4M-$8.6M

More on JUNS.

Figures from Jupiter Neurosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.